Moberg Pharma to Expand Board of Directors and Withdraw Share Issue Authorization

STOCKHOLM, September 3^rd, 2025, Moberg Pharma AB (OMX: MOB) today announces that shareholders representing more than 10 percent of the Company’s shares have proposed to expand the Board of Directors by two additional members. This proposal suggests increased shareholder representation and further focus on international sales at the Board level.

In addition, the proposal includes the intention to withdraw the authorization previously granted to issue new shares. This reflects Moberg Pharma’s solid financial position, as the Company is well-capitalized and does not foresee a need to utilize the authorization.

The current Board members have endorsed this proposal, which aims to further broaden the Board’s expertise and governance capacity in line with Moberg Pharma’s growth strategy. The proposal will be addressed at an Extraordinary General Meeting. A formal notice of the EGM will be provided in a subsequent press release.